Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Krystyna, Honczarenko"'
Autor:
Wioletta Pawlukowska, Karolina Skonieczna-Żydecka, Iwona Rotter, Krystyna Honczarenko, Przemysław Nowacki
Publikováno v:
BMC Neurology, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Evaluation of speech disorders in PD taking into account sociodemographic conditions is not frequent. This paper aims to establish correlations between articulation disorders in PD patients and factors such as the patients’ sex,
Externí odkaz:
https://doaj.org/article/a90ccf3593c24b1495a6636206653038
Autor:
Monika Gołąb-Janowska, Dariusz Kotlęga, Krzysztof Safranow, Agnieszka Meller, Anna Budzianowska, Krystyna Honczarenko
Publikováno v:
Parkinson's Disease, Vol 2016 (2016)
Introduction. Fatigue syndrome is one of the nonmotor symptoms in Parkinson’s disease (PD). The aim of the study was assessment of prevalence of fatigue syndrome in PD and answering the question what are the independent risk factors connected with
Externí odkaz:
https://doaj.org/article/ff4114e435cf4d7aba32019b3b195de3
Autor:
Krzysztof Safranow, Agnieszka Meller, Krystyna Honczarenko, Anna Budzianowska, Monika Gołąb-Janowska, Dariusz Kotlęga
Publikováno v:
Parkinson's Disease
Parkinson's Disease, Vol 2016 (2016)
Parkinson's Disease, Vol 2016 (2016)
Introduction.Fatigue syndrome is one of the nonmotor symptoms in Parkinson’s disease (PD). The aim of the study was assessment of prevalence of fatigue syndrome in PD and answering the question what are the independent risk factors connected with i
Autor:
Krzysztof Safranow, Barbara Nowacka, Andrzej Potemkowski, Wojciech Lubiński, Krystyna Honczarenko
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Background The aim of this study was to determine the type and frequency of ophthalmologic changes occurring in patients with Parkinson disease (PD). Material/Methods One hundred consecutive patients (196 eyes) with idiopathic PD and a control group
Autor:
Marek Droździk, Monika Deptuła-Jarosz, Anna Roszmann, Jarosław Sławek, Monika Gołąb-Janowska, Monika Białecka, Piotr Robowski, Monika Mak, Mateusz Kurzawski, Krystyna Honczarenko, Emilia J. Sitek
Publikováno v:
Neuroscience Letters. 561:86-90
Brain-derived neurotrophic factor (BDNF) is a neurotrophin widely expressed in the mammalian brain, regulating neuronal survival and known to influence dopaminergic neurons and cognitive processes. The present study investigated the BDNF Val66Met pol
Publikováno v:
Neurologia i Neurochirurgia Polska. 47:263-270
The aim of the study was to discuss physiology and pathology of speech and review of the literature on speech disorders in Parkinson disease. Additionally, the most effective methods to diagnose the speech disorders in Parkinson disease were also str
Autor:
Jarosław Sławek, Marek Droździk, Agnieszka Gorzkowska, Monika Białecka, Mateusz Kurzawski, Monika Gołąb-Janowska, Krystyna Honczarenko, Emilia J. Sitek, Monika Mak, Monika Jarosz, Ewa Koziorowska-Gawron, Sławomir Budrewicz, Piotr Robowski, Anna Roszmann
Publikováno v:
Pharmacogenetics and Genomics. 22:716-724
Elevated plasma homocysteine (Hcy) concentration is an independent risk factor for cardiovascular disease, and its involvement in endothelial cell dysfunction is well established. However, the role of Hcy and folate in the pathogenesis of Parkinson's
Autor:
Kornel Chełstowski, Karolina Kłoda, M. Jastrzebska, Krystyna Honczarenko, Małgorzata Kozłowska-Wojciechowska, Artur Mierzecki, Marek Naruszewicz
Publikováno v:
Postępy Higieny i Medycyny Doświadczalnej, Vol 66, Iss 855199, Pp 696-701 (2012)
Scopus-Elsevier
ResearcherID
Scopus-Elsevier
ResearcherID
Introduction Folic acid (FA) may delay the formation of atherosclerotic lesions. Increased plasma levels of von Willebrand factor (VWF) are observed in cardiovascular disease, which leads to higher risk of thrombosis. Fibrinogen (Fb) is a well-docume
Autor:
Claudia Trenkwalder, Bryan Kies, Monika Rudzinska, Jennifer Fine, Janos Nikl, Krystyna Honczarenko, Peter Dioszeghy, Dennis Hill, Tim Anderson, Vilho Myllyla, Jan Kassubek, Malcolm Steiger, Marco Zucconi, Eduardo Tolosa, Werner Poewe, Erwin Surmann, John Whitesides, Babak Boroojerdi, Kallol Ray Chaudhuri, null the RECOVER Study Group
Publikováno v:
Movement Disorders
In a multinational, double-blind, placebo-controlled trial (NCT00474058), 287 subjects with Parkinson's disease (PD) and unsatisfactory early-morning motor symptom control were randomized 2:1 to receive rotigotine (2–16 mg/24 hr [n = 190]) or place
Publikováno v:
Neurologia i Neurochirurgia Polska. 44:560-566
Background and purpose The evaluation of quality of life (QoL) is one of the most important factors in complex care of patients. The aim of the study was to estimate the usefulness of the shortened QoL-evaluating scale ALSAQ-5 in patients with amyotr